Progress in Tissue Engineering to Drive Global Market

The past couple of decades have witnessed significant progress in technology that has played a key role in improving the different cardiac treatments and patient outcomes. Advancements in biomedicine have led to an increase in the deployment of natural bio polyesters such as polyhydroxyalkanoates (PHA) for an array of applications. As PHAs are biodegradable, biocompatible, and non-toxic, they are used in multiple applications as biomaterials. PHAs are also used in the implantology space as valves and sutures in the tissue engineering field as substitutes for a bone graft and cardiovascular patches. The significant rise in the number of congenital & acquired cardiovascular and soft tissue anomalies, rising demand for biologics for hernia and other soft tissue repair, and rapid progress in biomaterial and tissue engineering are some of the major factors that are expected to drive the cardiovascular & soft tissue repair patch market during the forecast period (2019-2027).

Research and development activities in the cardiovascular & soft tissue repair patch market are on the rise as healthcare providers continue to find new materials that will improve the effectiveness of these patches. Growing adoption of cardiovascular & soft tissue repair patches particularly for cardiac tissue engineering is expected to be a major driver that is projected to steer the global cardiovascular & soft tissue repair patch market past the ~US$ 4.4 Bn mark by the end of 2027.

cardiovascular soft tissue repair patch market infographic

To know the scope of our report Get a Sample on Cardiovascular & Soft Tissue Repair Patch Market

Improvements in Bio-based Techniques to Treat Cardiac Regeneration Likely to Fuel Demand

Cardiovascular diseases are the leading causes of death worldwide and the numbers surge each year. Of all major cardiovascular diseases, the prevalence of myocardial infarction (MI) is the highest. Another major cardiovascular condition that is likely to be a burden on the global healthcare systems is heart failure wherein the heart loses its functional capabilities. While there is no concrete treatment for heart failure, research and development activities continue to open up new opportunities in this field.

Get a glimpse of the in-depth analysis through our Report Brochure

In the past couple of decades, tissue regeneration to enhance cardiac degeneration and mitigate heart failure has emerged as an ideal solution wherein cardiovascular & soft tissue repair patches made of biomaterials are used. Apart from tissue engineering, noteworthy advancements in regenerative medicine have also opened up new opportunities for stakeholders in the cardiovascular & soft tissue repair patch market. Over the past few years, participants of the cardiovascular & soft tissue repair patch market are focusing on the development of biomaterial-based strategies to overcome cardiac regeneration post-myocardial infarction. In the current scenario, the two major techniques deployed for tissue engineering include cardiac patches and in situ gelling systems. Cardiovascular & soft tissue repair patches consist of cells and bioactive molecules that aid in the therapeutic healing and repair of soft tissues. Despite emerging as one of the most reliable and effective tissue engineering techniques, cardiovascular & soft tissue repair patches have received flak, as they require invasive surgeries for implantation. In the past few years, in situ gel systems gaining popularity. However, it could dent the prospects of cardiovascular & soft tissue repair patches in the near future.

R&D Paves Way for New Cardiovascular & Soft Tissue Repair Patches

Research and development activities have been critical in the field of biomedicine and biomedical engineering. Witnessing the growing demand for efficient solutions to repair or heal the structural changes of the heart post-myocardial infarction treatment has encouraged research and development in the current cardiovascular & soft tissue repair patch market. While stem cell therapies have offered significant promise in providing assistance for cardiac repair, the low retention capacity of the transplanted stem cells poses a major hurdle. Various drawbacks of alternative techniques to aid cardiac repair have encouraged researchers to focus on the discovery of new solutions.

For instance, a group of researchers from the U.S. and South Korea designed a new stretchable cardiovascular & soft tissue repair patch made using a cell-derived extracellular matrix (ECM). According to the researchers, ECM can play an important role in enhancing the adhesion of stem cells and accelerate the recovery process. Investments in research and development activities are expected to grow at a steady pace in the coming years due to which, new therapeutic cardiovascular & soft tissue repair patches are being developed using new biomaterials.

cardiovascular soft tissue repair patch market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

The global cardiovascular & soft tissue repair patch market is expected to grow at an impressive CAGR of ~10% during the forecast period. The market growth can be attributed to a range of factors, including rise in the prevalence of congenital & acquired cardiovascular and soft tissue anomalies and ascending demand for biologics for hernia and a range of other soft tissue repair applications. Stakeholders in the current cardiovascular & soft tissue repair patch market should focus on research and development activities to develop new and effective therapeutic cardiac patches. In addition, developments in the biomaterial and tissue engineering space are further expected to boost the prospects of the market for cardiovascular & soft tissue repair patches.

Cardiovascular & Soft Tissue Repair Patch Market: Overview

  • According to Transparency Market Research’s latest market report on the global cardiovascular & soft tissue repair patch market for the historical period (2017–2018) and forecast period (2019–2027), increase in geriatric population and rise in prevalence of congenital & acquired cardiovascular and soft tissue anomalies are projected to boost the growth of the global cardiovascular & soft tissue repair patch market during the forecast period. Moreover, inclination toward minimally invasive procedures is anticipated to fuel the growth of the global cardiovascular & soft tissue repair patch market.
  • According to the report, the global cardiovascular & soft tissue repair patch market was valued at US$ 1.9 Bn in 2018 and is expected to expand at a CAGR of ~10% from 2019 to 2027

Rise in Prevalence of Congenital & Acquired Cardiovascular and Soft Tissue Anomalies: Key Drivers

  • The number of people with congenital heart defects is increasing across the globe due to changes in lifestyle, dietary habits, and physical inactivity. Rise in prevalence of congenital heart defects such as atrial septal defects and ventricular septal defects is likely to fuel the growth of the global cardiovascular & soft tissue repair patch market.
  • According to the Centers for Disease Control and Prevention, an estimated 1% (40,000) babies are born with congenital heart defect in the U.S. every year, and ventricular septal defect (VSD) is the most common heart defect
  • Rise in demand for biologics, owing to increase in soft tissue repair procedures is likely to propel the cardiovascular & soft tissue repair patch market. According to the U.S. Food and Drug Administration, over 1 million hernia repairs are performed in the U.S. each year.
  • Increase in incidence of abdominal and other types of hernia, surge in usage of biologic patches i.e., xenogeneic patch & allogeneic patch, and inclination toward minimally invasive procedures leading to rise in demand for biologic cardiovascular & soft tissue repair patch products

Increase in Geriatric Population

  • The geriatric population is at high risk of developing heart-related problems. Aging leads to accentuated adverse remodeling and increased dysfunction of cardiac mechanism. As the population continues to age, older patients are being referred for repair of acquired VSD. Hence, increase in the geriatric population is projected to accelerate the growth of the cardiovascular & soft tissue repair patch market during the forecast period.
  • According to the U.S. Department of Health & Human Product estimates, the U.S. will have about 72.1 million elderly people by 2030, which is more than twice the number in 2000
  • According to World Population Prospects: the 2019 Revision, the population aged 65 and above is increasing faster than all other age groups across the globe

Availability of Alternate Treatments and Complications Associated with Patches Restrain Global Market

  • Cardiovascular & soft tissue repair are common procedures performed across the world. Herniorrhaphy and hernioplasty are the alternative treatments for hernia repair.
  • Mesh for hernia repair and valve for cardiovascular repair are used significantly across the globe. Hence, alternative treatments are likely to hamper the growth of the cardiovascular & soft tissue repair market.
  • Adhesion, seroma, recurrence of soft tissue defects or hernia, allergic reactions, and hematomas are the complications associated with patches which restrict their usage. This factor hampers the growth of the global cardiovascular & soft tissue repair patch market.

Cardiovascular & Soft Tissue Repair Patch Market: Competition Landscape

  • This report profiles major players in the global cardiovascular & soft tissue repair patch market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global cardiovascular & soft tissue repair patch market is moderately fragmented, with presence of a small number of large players in international markets and large number of small players in regional markets. Top 4 to 5 players hold majority share of the global cardiovascular & soft tissue repair patch market. Prominent players operating in the global cardiovascular & soft tissue repair patch market include
    • W. L. Gore & Associates, Inc.
    • BD, Edwards Lifesciences Corporation
    • CryoLife, Inc.
    • Baxter
    • Johnson & Johnson (Medical Devices Business Services, Inc.)
    • Aesculap, Inc. (B. Braun company)
    • Nurami Medical Nanofiber Technology
    • Medtronic
    • FOC Medical S.A.
    • Medprin Regenerative Medical Technologies Co., Ltd.
    • CorMatrix, Inc.
    • Terumo Corporation
    • Lamed GmbH
    •  South America Implants S.A.

Cardiovascular & Soft Tissue Repair Patch Market: Key Developments

  • Leading players in the global cardiovascular & soft tissue repair patch market are engaged in the development and approval of new products, merger & acquisitions, and collaborations. Strategies adopted by key players are likely to boost the growth of the global cardiovascular & soft tissue repair patch market. Strategies adopted by the players in the global cardiovascular & soft tissue repair patch market are:
    • In December 2019, Baxter acquired Seprafilm to expand its advanced surgery portfolio
    • In June 2019, CorMatrix, Inc. announced the U.S. Food and Drug Administration approval for the Cor PATCH for pericardial tissue repair and support in adult patients
    • In September 2018, South America Implants S.A. entered into a distribution agreement with Minimal Medics Co. to expand internationally
    • In November 2016, W. L. Gore & Associates, Inc. joined with leaders across the vascular and endovascular community in honoring five North American physicians
  • The report on the global cardiovascular & soft tissue repair patch market discusses individual strategies, followed by company profiles of manufacturers of cardiovascular & soft tissue repair patches. The competitive landscape section is included in the cardiovascular & soft tissue repair patch market report to provide readers with a dashboard view and a company market share analysis of key players operating in the global cardiovascular & soft tissue repair patch market.

Cardiovascular & Soft Tissue Repair Patch Market - Scope of the Report

TMR’s report on the global cardiovascular & soft tissue repair patch market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2019 to 2027. The report provides the revenue of the global cardiovascular & soft tissue repair patch market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global cardiovascular & soft tissue repair patch market during the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global cardiovascular and soft tissue repair patch market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the global cardiovascular and soft tissue repair patch market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global cardiovascular and soft tissue repair patch market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global cardiovascular and soft tissue repair patch market.

The report delves into the competitive landscape of the global cardiovascular and soft tissue repair patch market. Key players operating in the global cardiovascular & soft tissue repair patch market are identified, and each one of these is profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global cardiovascular & soft tissue repair patch market that have been profiled in this report.

Key Questions Answered in Cardiovascular & Soft Tissue Repair Patch Market Report

  • What is the scope of growth of product companies in the global cardiovascular & soft tissue repair patch market?
  • What will be the Y-o-Y growth of the global cardiovascular & soft tissue repair patch market between 2019 and 2027?
  • What is the influence of changing trends in technologies on the global cardiovascular & soft tissue repair patch market?
  • Will North America continue to be the most profitable regional market for cardiovascular & soft tissue repair patch providers?
  • Which factors will hamper the growth of the global cardiovascular & soft tissue repair patch market during the forecast period?
  • Which are the leading companies in the global cardiovascular & soft tissue repair patch market?

Research Methodology

A unique research methodology has been utilized by TMR to conduct a comprehensive research on the global cardiovascular and soft tissue repair patch market, and arrive at conclusions on the growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary sources referred to by analysts during the production of the global cardiovascular & soft tissue repair patch market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the global cardiovascular & soft tissue repair patch market as primary sources.

These primary and secondary sources have provided exclusive information during interviews, which serves as a validation from the cardiovascular & soft tissue repair patch market leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global cardiovascular & soft tissue repair patch market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on growth prospects of the global cardiovascular & soft tissue repair patch market more reliably and accurately.

Cardiovascular & Soft Tissue Repair Patch Market - Segmentation

Product

Synthetic Patch

Biologic Patch

  • Xenogeneic Patch
  • Allogeneic Patch

Application

Cardiovascular Repair

  • Cardiac Reconstruction
  • Vascular Reconstruction

Soft Tissue Repair

  • Abdominal Wall Reconstruction
  • Thoracic Wall Reconstruction
  • Dural Reconstruction
  • Hernia Repair
  • Others

End User

Hospitals

Ambulatory Surgical Centers

Specialty Clinics

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Cardiovascular Soft Tissue Repair Patch Market

Buy Now